Conversion From Fast Acting Oral Opioids to Abstral®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01315886
Recruitment Status : Terminated (Recruitment difficulties)
First Posted : March 15, 2011
Last Update Posted : April 5, 2017
Information provided by (Responsible Party):
Orexo AB

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 7, 2011
  Actual Study Completion Date : December 7, 2011